Biotricity Inc. (Biotricity) has signed a distribution agreement with one of the Top 10 US medical device distributors to distribute its cardiac monitoring solutions, Bioflux and Biotres. With the commercialization of its Bioflux and Biotres products, Biotricity has increased its total addressable market from $1 billion to approximately $6 billion.
Biotricity Inc. (Biotricity) today announced that its Bioheart device has been named to TIME’s list of the Best Inventions of 2022. Bioheart is the first of its kind – a continuous heart rhythm monitor using advanced technology to deliver unlimited heart data insights.
Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, today announced the U.S. launch of Biocare Cardiac. The national roll-out follows two successful pilot programs in Oklahoma City with CardioVascular Health Clinic, a medical facility providing high-quality cardiovascular care to more than 40,000 patients, and a four-month pilot with Lexington Heart Specialists in Kentucky, a medical practice providing high-quality cardiovascular care to more than 20,000 patients.
Biotricity Inc. (Biotricity) today announced a significant milestone of recording and analyzing over 2 billion heartbeats for Atrial Fibrillation (AFib), the most common type of cardiac arrhythmia and a leading cause of stroke. Bioflux®, Biotricity’s high-precision, single-unit mobile cardiac telemetry device that provides real-time monitoring and transmission of the patient’s ECG information, has captured billions of heartbeats to date, monitored in real-time by Bioflux’s built in algorithms, certified cardiac technicians and benchmarked by Artificial Intelligence (AI).
Biotricity Inc. (Biotricity), today announced that it will be carrying out an NIH-sponsored Phase I study of Bioflux-AI, Biotricity’s innovative artificial intelligence-driven (‘AI’) system of real-time monitoring and prediction technology, in subjects with Chronic Kidney Disease (‘CKD’). The risk of ischemic and hemorrhagic stroke is 5 to 30 times higher in patients with CKD and has a mortality rate of up to three times that of the general population. Effective stroke risk prediction is currently flawed in CKD patients because comorbidities often remain undiagnosed and stroke risk stratification schemes do not consider stages of CKD. Additionally, the detection of stroke-risk variations due to dialysis requires real-time risk monitoring, which is unavailable to date.
Wedge Networks Inc. (Wedge) today announced its partnership with SecureServ, an Australian-based cyber security solutions and network performance distributor. The partnership will afford SecureServ the opportunity to deliver powerful new threat prevention with innovative solutions for Enterprises, Small Businesses, Government Departments, Service Providers and Data Centres, while simultaneously expanding its partner community in the region.
BlackBerry Limited and L-SPARK, Canada’s largest software-as-a-service accelerator, today announced the four winning companies that will make up the third cohort of their joint accelerator program, which aims to grow Canadian technology companies that are focused on connected vehicle technologies. Deeplite, Raven Connected, Sensor Cortek and Wedge Networks will have access to BlackBerry IVY to deliver high-impact transportation use cases leveraging in-vehicle data
Biotricity Inc. (Biotricity) today announced that the company is expected to join the Russell Microcap® Index at the conclusion of the 2022 Russell indexes annual reconstitution, effective after the US market opens on June 27, 2022. Membership in the Russell Microcap® Index, which remains in place for one year, includes inclusion in the appropriate growth and value style indexes.
Wedge Networks Inc. (Wedge) is invited to join MobilityXlab, a collaboration hub founded in 2017 by global companies to create and innovate future mobility solutions. Wedge will participate to co-create solutions for safe and secure mobility in partnership with seven world-leading industry partners: CEVT, Ericsson, Polestar, Veoneer, Volvo Cars, Volvo Group, and Zenseact.
Wedge Networks Inc. (Wedge) is introducing a new generation of its Intelligent Web Shield™ (IWS) solution available to all customers and partners using WedgeARP™ v2.6 and above to support up and coming SASE use cases. The ever-expanding SASE market is witnessing novel use cases such as 5G Edge/MEC services, smart infrastructure, smart manufacturing and CAV/ITS all of which require zero trust for both access and network traffic at the edge.
